DK5792A - Anvendelse af sulfaterede sukkerarter - Google Patents

Anvendelse af sulfaterede sukkerarter Download PDF

Info

Publication number: DK5792A
Authority: DK; Denmark
Prior art keywords: complex; salt; preventing; sulphated; skin
Prior art date: 1987-12-21

Application number

DK005792A

Other languages

English (en)

Other versions

DK169018B1 (da

DK5792D0 (da

Inventor

Daniel Bar-Shalom

Niels Bukh

Original Assignee

Bukh Meditec

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-12-21

Filing date

1992-01-17

Publication date

1992-01-17

1987-12-21 Priority claimed from DK674087A external-priority patent/DK674087D0/da

1992-01-17 Application filed by Bukh Meditec filed Critical Bukh Meditec

1992-01-17 Priority to DK005792A priority Critical patent/DK169018B1/da

1992-01-17 Publication of DK5792A publication Critical patent/DK5792A/da

1992-01-17 Publication of DK5792D0 publication Critical patent/DK5792D0/da

1994-02-18 Priority to DK199400203A priority patent/DK174560B1/da

1994-08-01 Application granted granted Critical

1994-08-01 Publication of DK169018B1 publication Critical patent/DK169018B1/da

Links

150000002016 disaccharides Chemical class 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 2
229930006000 Sucrose Natural products 0.000 abstract 2
239000005720 sucrose Substances 0.000 abstract 2
230000037303 wrinkles Effects 0.000 abstract 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
230000032683 aging Effects 0.000 abstract 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
229910052782 aluminium Inorganic materials 0.000 abstract 1
239000004411 aluminium Substances 0.000 abstract 1
210000002808 connective tissue Anatomy 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
210000004877 mucosa Anatomy 0.000 abstract 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
229910052708 sodium Inorganic materials 0.000 abstract 1
239000011734 sodium Substances 0.000 abstract 1
MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 abstract 1
229960004291 sucralfate Drugs 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/58—Metal complex; Coordination compounds
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Virology (AREA)
Gerontology & Geriatric Medicine (AREA)
Inorganic Chemistry (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Cosmetics (AREA)
Seasonings (AREA)
Polymerisation Methods In General (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK005792A 1987-12-21 1992-01-17 Anvendelse af sulfaterede sukkerarter DK169018B1 (da)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
DK005792A DK169018B1 (da)	1987-12-21	1992-01-17	Anvendelse af sulfaterede sukkerarter
DK199400203A DK174560B1 (da)	1987-12-21	1994-02-18	Anvendelse af sulfaterede sukkerarter til fremstilling af et præparat til behandling af skæl

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
DK674087		1987-12-21
DK674087A DK674087D0 (da)	1987-12-21	1987-12-21	Saarbehandlingsmiddel
DK505488		1988-09-09
DK505488A DK505488D0 (da)	1987-12-21	1988-09-09	Middel og anvendelse af samme
DK5792		1992-01-17
DK005792A DK169018B1 (da)	1987-12-21	1992-01-17	Anvendelse af sulfaterede sukkerarter

Publications (3)

Publication Number	Publication Date
DK5792A true DK5792A (da)	1992-01-17
DK5792D0 DK5792D0 (da)	1992-01-17
DK169018B1 DK169018B1 (da)	1994-08-01

Family

ID=26067713

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
DK505488A DK505488D0 (da)	1987-12-21	1988-09-09	Middel og anvendelse af samme
DK151690A DK151690A (da)	1987-12-21	1990-06-21	Anvendelse af sucralfat
DK151590A DK165357C (da)	1987-12-21	1990-06-21	Anvendelse af sulfaterede disaccharid eller et salt eller kompleks deraf til fremstilling af et laegemiddel til profylakse eller behandling af inflammation
DK005792A DK169018B1 (da)	1987-12-21	1992-01-17	Anvendelse af sulfaterede sukkerarter

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
DK505488A DK505488D0 (da)	1987-12-21	1988-09-09	Middel og anvendelse af samme
DK151690A DK151690A (da)	1987-12-21	1990-06-21	Anvendelse af sucralfat
DK151590A DK165357C (da)	1987-12-21	1990-06-21	Anvendelse af sulfaterede disaccharid eller et salt eller kompleks deraf til fremstilling af et laegemiddel til profylakse eller behandling af inflammation

Country Status (9)

Country	Link
EP (3)	EP0640346B1 (da)
JP (2)	JPH04500797A (da)
KR (2)	KR930003117B1 (da)
AT (2)	ATE197546T1 (da)
AU (2)	AU2914589A (da)
DE (2)	DE3856442T2 (da)
DK (4)	DK505488D0 (da)
HK (1)	HK56396A (da)
WO (2)	WO1989005645A1 (da)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK674087D0 (da) *	1987-12-21	1987-12-21	Bar Shalom Daniel	Saarbehandlingsmiddel
DK505488D0 (da) *	1987-12-21	1988-09-09	Bar Shalom Daniel	Middel og anvendelse af samme
US5202311A (en) *	1988-08-19	1993-04-13	Children's Medical Center Corporation	Stabilized fgf composition
US5618798A (en) *	1989-04-20	1997-04-08	Bar-Shalom; Daniel	Use of sucralfate to treat baldness
IT1230157B (it) *	1989-06-16	1991-10-14	Lisapharma Spa	Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
IL95642A0 (en) *	1989-09-15	1991-06-30	Pehrom Pharmaceutical Corp	Topical preparations for treatment of ulcers and other lesions
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease
ATE209498T1 (de) *	1990-08-31	2001-12-15	Chugai Pharmaceutical Co Ltd	Herstellung einer vorratslösung von in wasser suspendiertem sucralfat
US5639738A (en) *	1992-02-20	1997-06-17	Hyal Pharmaceutical Corporation	Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
DE69120933T2 (de) *	1991-04-18	1997-01-16	Baldacci Lab Spa	Topische Anwendung von Glycosaminoglykane zur Prävention und Behandlung der Zervikal- oder Vaginalerkrankungen
US5990095A (en) *	1991-07-03	1999-11-23	Hyal Pharmaceutical Corporation	Use of hyaluronic acid and forms to prevent arterial restenosis
US5817644A (en) *	1991-07-03	1998-10-06	Hyal Pharmaceutical Corporation	Targeting of dosages of medicine and therapeutic agents
US5792753A (en) *	1991-07-03	1998-08-11	Hyal Pharmaceutical Corporation	Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
IT1251151B (it) *	1991-08-05	1995-05-04	Fidia Spa	Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6147059A (en) *	1992-02-20	2000-11-14	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
US6114314A (en) *	1992-02-21	2000-09-05	Hyal Pharmaceutical Corp.	Formulations containing hyaluronic acid
EP0591546A4 (en) *	1992-03-28	1994-06-01	Dott Ltd Comp	External preparation for curing damage to skin
US6750207B1 (en) *	1992-05-01	2004-06-15	Yeda Research And Development Co. Ltd.	Compositions for the regulation of cytokine activity
DK86492D0 (da) *	1992-06-30	1992-06-30	Bukh Meditec	Laegemiddel
AU6362594A (en) *	1993-03-10	1994-09-26	Miles Inc.	Hyaluronic acid used as a cancer treatment
US20040208875A1 (en)	1995-03-15	2004-10-21	Queen's University At Kingston	Method for treating amyloidosis
WO1994022437A2 (en) *	1993-03-29	1994-10-13	Queen's University At Kingston	Method for treating amyloidosis
US5434144A (en) *	1994-03-04	1995-07-18	The Procter & Gamble Company	Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles
MX9604411A (es) *	1994-03-28	1997-12-31	Univ Columbia	Composicion para inactivar irritantes en fluidos.
ATE213635T1 (de) *	1994-04-26	2002-03-15	Chugai Pharmaceutical Co Ltd	Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung
SE9401826D0 (sv) *	1994-05-27	1994-05-27	Pharmacia Ab	Anti-Helicobacter pyroli substance
US5783568A (en) *	1994-06-10	1998-07-21	Sugen, Inc.	Methods for treating cancer and other cell proliferative diseases
CA2212046A1 (en) *	1995-02-02	1996-08-08	Chugai Seiyaku Kabushiki Kaisha	Sucralfate preparations
WO1996024362A1 (en) *	1995-02-07	1996-08-15	Shiseido Company, Ltd.	Antiinflammatory agents
US6537977B1 (en) *	1995-09-19	2003-03-25	Seikagaku Corporation	Anti-inflammatory agent
JP3263598B2 (ja) *	1995-11-01	2002-03-04	有限会社ドット	経鼻吸収用生理活性ペプチド組成物
US5837266A (en) *	1996-04-30	1998-11-17	Hydromer, Inc.	Composition, barrier film, and method for preventing contact dermatitis
CH690719A5 (it) *	1996-08-19	2000-12-29	Rotta Res B V Amsterdam Swiss	Procedimento per la preparazione di sali misti della glucosamina.
WO1998017282A1 (en) *	1996-10-23	1998-04-30	Vertex Pharmaceuticals Incorporated	Methods of using sucrose octasulfate to treat or prevent enveloped virus infection
GB9625193D0 (en)	1996-12-04	1997-01-22	Ml Lab Plc	Treatment of highly vascular tumours
WO1999026636A1 (fr) *	1997-11-24	1999-06-03	Zhongming Zeng	Formulation pharmaceutique de stimulation de la croissance de bacilles gram positifs et d'augmentation de l'acidite du vagin et leur utilisation
FI974321A0 (fi)	1997-11-25	1997-11-25	Jenny Ja Antti Wihurin Rahasto	Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
WO1999043333A1 (en) *	1998-02-27	1999-09-02	The Althexis Company	Therapeutic and prophylactic uses of negatively charged substituted disaccharides
US5902800A (en) *	1998-03-27	1999-05-11	Glenpharma	Dextran formulations and method for treatment of inflammatory joint disorders
US7906153B2 (en)	1998-04-08	2011-03-15	Theta Biomedical Consulting & Development Co., Inc.	Anti-inflammatory compositions for treating multiple sclerosis
BR9806540C1 (pt) *	1998-06-09	2001-05-08	Akira Yoshitome	Produto farmacêutico para tratamento de hemofilia e de bronquite asmática
AU2007200916B2 (en) *	1998-10-05	2009-09-17	Kabushiki Kaisha Yakult Honsha	Antibacterial agents and process for producing the same
KR100698232B1 (ko) *	1998-10-05	2007-03-21	가부시키가이샤 야쿠루트 혼샤	항균제 및 그것의 제조방법
EP1139746A4 (en) *	1998-12-22	2003-09-17	Univ North Carolina	CONNECTIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY DISEASES AND THE ADMINISTRATION OF MEDICINAL SUBSTANCES
US6964949B2 (en)	2000-05-24	2005-11-15	Shanghai Jiao Da Onlly Co., Ltd.	Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
BRPI0101486B1 (pt) *	2001-04-17	2017-09-19	Cristália Produtos Químicos Farmacêuticos Ltda.	Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
US7285536B2 (en)	2001-12-05	2007-10-23	Yeda Research And Development Co., Ltd.	Anti-cancer therapeutic compounds
DE10161149B4 (de) *	2001-12-12	2007-03-08	Ursapharm Arzneimittel Gmbh & Co. Kg	Verwendung von Heparin-haltigem Ophthalmikum
US20050100566A1 (en) *	2001-12-13	2005-05-12	Dia Pharmaceutical Co., Ltd.	Gel composition for external use, pad materials and pad materials to be packed in blister containers
US7879365B2 (en)	2002-02-07	2011-02-01	The Trustees Of Columbia University In The City Of New York	Zinc salt compositions for the prevention of dermal and mucosal irritation
CA2475224C (en)	2002-02-07	2011-11-01	The Trustees Of Columbia University In The City Of New York	Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
US7265097B2 (en)	2002-08-20	2007-09-04	Chitogenics, Inc.	Methods of drug delivery using sulphated chitinous polymers
US20060234977A1 (en) *	2003-01-23	2006-10-19	Gina Wenham	Antiviral compostion comprising a sulphated glucose polymer and a bacteriostatic agent
US7414076B2 (en)	2003-06-23	2008-08-19	Neurochem (International) Limited	Methods and compositions for treating amyloid-related diseases
US7244764B2 (en)	2003-06-23	2007-07-17	Neurochem (International) Limited	Methods and compositions for treating amyloid-related diseases
BRPI0412675A (pt)	2003-07-17	2006-10-03	Univ Columbia	composições antimicrobianas contendo combinações sinergìsticas de compostos de amÈnio quaternário e óleos essenciais e/ou constituintes
CA2576131C (en) *	2004-08-05	2012-04-24	Ivax Drug Research Institute Ltd.	Polysulfated glycosides and salts thereof
US20080249165A1 (en) *	2004-08-05	2008-10-09	Ivax Drug Research Institute Ltd.	Glycosides and Salts Thereof
WO2006017752A2 (en) *	2004-08-05	2006-02-16	Ivax Corporation	Sulfated oligosaccharides
WO2006085149A2 (en)	2004-12-22	2006-08-17	Neurochem (International) Limited	Methods and compositions for treating amyloid-related diseases
DE602005008964D1 (de) *	2005-09-16	2008-09-25	Italfar Societa A Responsabili	Wundheilende pharmazeutische Zusammensetzung enthaltend Sucralfat, Glycin, Aluminium Acetat und Vitamine
MX2008008213A (es)	2005-12-22	2008-09-03	Neurochem Int Ltd	Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
KR20080025900A (ko) *	2006-09-19	2008-03-24	(주) 서울바이오메드	글루코사민 또는 글루코사민 유도체를 포함하는 알레르기성결막염 치료용 조성물 및 이를 사용하여 알레르기성결막염을 치료하는 방법
KR101608445B1 (ko)	2006-10-12	2016-04-01	비에이치아이 리미티드 파트너쉽	3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
GB0622688D0 (en)	2006-11-14	2006-12-27	Diosamine Dev Corp	Novel compounds
GB2450087A (en) *	2007-06-11	2008-12-17	Diosamine Dev Corp	Use of sulphated saccharides in the treatment of inflammatory and/or auto-immune diseases
WO2010033408A1 (en)	2008-09-17	2010-03-25	Mcgrath Patrick D	Antimicrobial sucralfate paste methods and compositions
US9440099B2 (en) *	2008-11-20	2016-09-13	Laboratori Derivati Organici Spa	Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations
FR2953522B1 (fr) *	2009-12-07	2012-03-09	Fabre Pierre Dermo Cosmetique	Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques
FR2956322A1 (fr) *	2010-02-17	2011-08-19	Urgo Lab	Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie.
CA2790682C (en)	2010-03-03	2020-11-24	Neocutis Sa	Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
WO2012071611A1 (en) *	2010-12-01	2012-06-07	The Australian National University	Histone inhibition
ITMI20110033A1 (it) *	2011-01-17	2012-07-18	Biofarmitalia Spa	Composizione terapeutica mucoadesiva a base di acido ialuronico per la prevenzione e terapia di lesioni epiteliali, delle mucose del corpo umano
FR2975994B1 (fr) *	2011-05-31	2015-03-06	Fabre Pierre Dermo Cosmetique	Sucroses octasulfates de calcium, leur preparation et leurs applications pharmaceutiques et cosmetiques
FR2975993B1 (fr) *	2011-05-31	2013-06-28	Fabre Pierre Dermo Cosmetique	Sucroses octasulfates de magnesium, leur preparation et leurs applications pharmaceutiques et cosmetiques
FR2991876B1 (fr) *	2012-06-13	2014-11-21	Vivacy Lab	Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2993182B1 (fr)	2012-07-13	2014-10-17	Urgo Lab	Pansement a liberation prolongee d'actifs
US10716802B2 (en)	2013-03-15	2020-07-21	The Brigham And Women's Hospital, Inc.	Compounds to modulate intestinal absorption of nutrients
KR101649201B1 (ko) *	2014-01-22	2016-08-18	대구가톨릭대학교산학협력단	오만둥이 유래 황산다당을 유효성분으로 함유하는 피부 미백 및 주름 개선용 화장료 조성물
WO2017053970A1 (en)	2015-09-24	2017-03-30	The Brigham And Women's Hospital, Inc.	Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
FR3043556B1 (fr) *	2015-11-17	2020-01-10	Urgo Recherche Innovation Et Developpement	Utilisation de composes oligosaccharidiques pour activer l'angiogenese
FR3044555B1 (fr)	2015-12-07	2020-03-06	Centre National De La Recherche Scientifique - Cnrs -	Film comprenant un oligosaccharide polysulfate et un polycation et son procede de fabrication
FR3060392B1 (fr) *	2016-12-19	2019-07-12	Urgo Recherche Innovation Et Developpement	Utilisation de composes oligosaccharidiques pour activer l'epidermisation
IT201700047632A1 (it) *	2017-05-03	2018-11-03	Ricerfarma Srl	Composizioni topiche per mantenere e ripristinare l'omeostasi idrica della pelle

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4486416A (en) *	1981-03-02	1984-12-04	Soll David B	Protection of human and animal cells subject to exposure to trauma
FR2503563A1 (fr) *	1981-04-09	1982-10-15	Pos Lab	Composition pour collyre a base de sulfate de chondroitine a
DE3131811A1 (de) *	1981-08-12	1983-04-21	Serapharm - Michael Stroetmann, 4400 Münster	Heparinsalbe zur percutanen behandlung von thrombophlebitiden oder varizen
IT1189298B (it) *	1982-06-18	1988-02-04	Manetti & Roberts Italo Brit	Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
JPS5978116A (ja) *	1982-10-27	1984-05-04	Chugai Pharmaceut Co Ltd	スクラルフェ−ト製剤
US4640912A (en) *	1983-06-09	1987-02-03	Hausman Marvin S	Administration of "active" chondroitin sulfate A and "active" chondroitin sulfate C or mixtures thereof to mammals including humans
DE3323389A1 (de) *	1983-06-29	1985-01-10	B. Braun Melsungen Ag, 3508 Melsungen	Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden
AU555747B2 (en) *	1983-08-09	1986-10-09	Cilco Inc.	Chondroitin sulfate and sodium hyaluronate composition
CA1218601A (en) *	1983-09-02	1987-03-03	Angel B. Casillan	Sucralfate suspension
AU607690B2 (en) *	1985-12-24	1991-03-14	Marion Laboratories, Inc.	Use of synthetic sulfated saccharides to enhance wound healing
DK164199C (da) *	1986-05-16	1992-10-19	Chugai Pharmaceutical Co Ltd	Sucralfatpraeparat til anvendelse paa oesophagus mucosa
EP0254845A3 (en) *	1986-06-10	1989-04-19	Lescarden Inc.	Immune stimulation with chondroitin sulfate
DK505488D0 (da) *	1987-12-21	1988-09-09	Bar Shalom Daniel	Middel og anvendelse af samme

1988
- 1988-09-09 DK DK505488A patent/DK505488D0/da not_active Application Discontinuation
- 1988-12-21 EP EP94202490A patent/EP0640346B1/en not_active Expired - Lifetime
- 1988-12-21 KR KR1019890701562A patent/KR930003117B1/ko not_active Expired - Fee Related
- 1988-12-21 AT AT94202490T patent/ATE197546T1/de not_active IP Right Cessation
- 1988-12-21 EP EP89901101A patent/EP0420849A1/en not_active Withdrawn
- 1988-12-21 EP EP89901102A patent/EP0394333B1/en not_active Expired - Lifetime
- 1988-12-21 WO PCT/DK1988/000216 patent/WO1989005645A1/en not_active Ceased
- 1988-12-21 KR KR1019890701561A patent/KR900700108A/ko not_active Ceased
- 1988-12-21 WO PCT/DK1988/000217 patent/WO1989005646A1/en not_active Ceased
- 1988-12-21 AU AU29145/89A patent/AU2914589A/en not_active Abandoned
- 1988-12-21 JP JP1501021A patent/JPH04500797A/ja active Pending
- 1988-12-21 JP JP1501022A patent/JPH0739347B2/ja not_active Expired - Fee Related
- 1988-12-21 DE DE3856442T patent/DE3856442T2/de not_active Expired - Fee Related
- 1988-12-21 AT AT89901102T patent/ATE119778T1/de not_active IP Right Cessation
- 1988-12-21 AU AU29146/89A patent/AU631529B2/en not_active Ceased
- 1988-12-21 DE DE3853365T patent/DE3853365T2/de not_active Expired - Fee Related
1990
- 1990-06-21 DK DK151690A patent/DK151690A/da not_active IP Right Cessation
- 1990-06-21 DK DK151590A patent/DK165357C/da not_active IP Right Cessation
1992
- 1992-01-17 DK DK005792A patent/DK169018B1/da not_active IP Right Cessation
1996
- 1996-03-28 HK HK56396A patent/HK56396A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU2914589A (en)	1989-07-19
DK169018B1 (da)	1994-08-01
DK151690D0 (da)	1990-06-21
DK151690A (da)	1990-08-15
JPH04500798A (ja)	1992-02-13
EP0394333B1 (en)	1995-03-15
DK165357B (da)	1992-11-16
WO1989005645A1 (en)	1989-06-29
HK56396A (en)	1996-04-03
DK165357C (da)	1993-04-05
EP0640346B1 (en)	2000-11-15
JPH0739347B2 (ja)	1995-05-01
ATE119778T1 (de)	1995-04-15
AU631529B2 (en)	1992-12-03
KR900700109A (ko)	1990-08-11
DK151590A (da)	1990-08-14
DK151590D0 (da)	1990-06-21
ATE197546T1 (de)	2000-12-15
JPH04500797A (ja)	1992-02-13
EP0640346A1 (en)	1995-03-01
EP0420849A1 (en)	1991-04-10
DK5792D0 (da)	1992-01-17
DE3856442D1 (de)	2000-12-21
DE3856442T2 (de)	2001-05-10
DE3853365D1 (de)	1995-04-20
AU2914689A (en)	1989-07-19
KR900700108A (ko)	1990-08-11
DE3853365T2 (de)	1995-07-27
WO1989005646A1 (en)	1989-06-29
EP0394333A1 (en)	1990-10-31
KR930003117B1 (ko)	1993-04-19
DK505488D0 (da)	1988-09-09

Legal Events

Date	Code	Title	Description
1994-08-01	B1	Patent granted (law 1993)
2009-01-19	PUP	Patent expired

Publication	Publication Date	Title
AU607690B2 (en)	1991-03-14	Use of synthetic sulfated saccharides to enhance wound healing
AU570366B2 (en)	1988-03-10	Esterified oligosaccharides
FI102035B1 (fi)	1998-10-15	Sulfatoidun sakkaridin kosmeettinen käyttö
ES2065323T3 (es)	1995-02-16	Procedimiento de tratamiento del colageno en vista, particularmente, a facilitar su reticulacion y colageno obtenido por aplicacion de dicho procedimiento.
IT8449361A1 (it)	1986-06-27	Composizione cosmetica o dermatologica per la cura della pelle
FI902310A7 (fi)	1990-05-08	Hyaluronihappoon ja deoksiribonukleiinihappoon pohjautuva kosmeettinen vesipitoinen geeli ja sen valmistusmenetelmä
DK151590A (da)	1990-08-14	Anvendelse af sulfaterede sukkerarter
NO175750C (no)	1994-11-30	Vandig polysakkaridpreparat, fremgangsmåte for fremstilling derav og anvendelse av preparatet
BR8702377A (pt)	1988-11-29	Aditivo de agente de cura,composicao de adesivo curavel por inducao e processo para posicionar fixas pecas metalicas
AU7837287A (en)	1988-03-17	Infrared reflecting composition for topical application to the skin
BR9606559A (pt)	1998-07-07	Vidraca pronta para ser montada no quadro de um vão de janela processo de fabricação de uma vidraça e conjunto de montagem de uma vidraça no quadro de um vão de janela
IT8223892A0 (it)	1982-10-22	Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle.
BR8801797A (pt)	1988-11-16	Agente de revestimento aquoso,processo para sua preparacao e aplicacao
ES516384A0 (es)	1983-06-16	"metodo para reducir la reflexion de la luz de superficies de vidrio".
IE873478L (en)	1988-06-22	Use of 13-cis retinoic acid
BR9106049A (pt)	1992-11-17	Solucao aquosa de revestimento de conversao,e,processo para tratar uma superficie de aluminio ou de uma liga de aluminio
IT1098328B (it)	1985-09-07	Sale sodico della mercapropropionilglicina,processo per la sua preparazione e suoi impieghi terapeutici
IT1075117B (it)	1985-04-22	Complesso polisaccaridico arterioso,processo per la sua preparazione e suo impiego in terapia umana
BR7806735A (pt)	1979-05-08	Processo para fabricacao de sulfato de sodio,principalmente em sulfato de sodio contendo tracos de metionina,e produto obtido
GR900100746A (el)	1992-09-25	Σύν?εσις καλλυντικού.
IT1163959B (it)	1987-04-08	Agente per aumenare il tenore in zucchero di uve e anaassi e procedimento per applicarlo
BR9005102A (pt)	1991-09-17	Processo para fazer n,n,n',n'-tetra-alcoxi-metil-ciclo-hexano-carboguanaminas,produtos obtidos,e composicao de cura rapida
IT7722541U1 (it)	1979-04-20	Squadretta, atta a fungere da organo di collegamento per profilati, nella realizzazione di infissi e serramenti in genere, e presentante una doppia possibilita' di regolazione
IT8607109V0 (it)	1986-11-21	Cerniera per serramenti in alluminio e relativo metodo di unione agli stessi.
IT1174375B (it)	1987-07-01	Procedimento perfezionato, atto a consentiere la produzione di profilati in alluminio o leghe leggere, per ifissi e/o serramenti, provvisti di una discontinuita' strutturale